[go: up one dir, main page]

MX2018001219A - Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. - Google Patents

Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.

Info

Publication number
MX2018001219A
MX2018001219A MX2018001219A MX2018001219A MX2018001219A MX 2018001219 A MX2018001219 A MX 2018001219A MX 2018001219 A MX2018001219 A MX 2018001219A MX 2018001219 A MX2018001219 A MX 2018001219A MX 2018001219 A MX2018001219 A MX 2018001219A
Authority
MX
Mexico
Prior art keywords
preparing
pharmaceutical composition
same
storage stability
improved storage
Prior art date
Application number
MX2018001219A
Other languages
English (en)
Inventor
Oh Kim Bong
Chan MIN Bum
Yeong KIM Ji
Rim Kim Hye
Hyo Seo Min
Won Lee Sa
Woong Yi Yil
Woong Cho Joong
Ja Choi In
Original Assignee
Samyang Biopharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Biopharmaceuticals filed Critical Samyang Biopharmaceuticals
Publication of MX2018001219A publication Critical patent/MX2018001219A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/88—Post-polymerisation treatment
    • C08G63/90—Purification; Drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78—Preparation processes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78—Preparation processes
    • C08G63/82—Preparation processes characterised by the catalyst used
    • C08G63/823—Preparation processes characterised by the catalyst used for the preparation of polylactones or polylactides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78—Preparation processes
    • C08G63/82—Preparation processes characterised by the catalyst used
    • C08G63/85—Germanium, tin, lead, arsenic, antimony, bismuth, titanium, zirconium, hafnium, vanadium, niobium, tantalum, or compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se provee una composición farmacéutica que contiene un compuesto relacionado específico dentro de un límite especificado y un método para preparar la misma.
MX2018001219A 2015-07-28 2016-07-28 Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. MX2018001219A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150106626 2015-07-28
PCT/KR2016/008265 WO2017018816A1 (en) 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same

Publications (1)

Publication Number Publication Date
MX2018001219A true MX2018001219A (es) 2018-04-24

Family

ID=57884841

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018001219A MX2018001219A (es) 2015-07-28 2016-07-28 Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.

Country Status (13)

Country Link
EP (1) EP3328434A4 (es)
JP (1) JP6605706B2 (es)
KR (1) KR101748191B1 (es)
CN (2) CN111574702A (es)
AU (1) AU2016299544A1 (es)
BR (1) BR112018001736A2 (es)
CA (1) CA2993920A1 (es)
HK (1) HK1249439A1 (es)
IL (1) IL257185A (es)
MX (1) MX2018001219A (es)
RU (1) RU2018107052A (es)
WO (1) WO2017018816A1 (es)
ZA (1) ZA201801189B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113424057B (zh) * 2019-04-19 2024-04-05 海正生物制药有限公司 组合物中泊洛沙姆188的检测方法
KR102688394B1 (ko) * 2020-12-10 2024-07-25 주식회사 삼양홀딩스 재건 시간을 단축할 수 있는 고분자 미셀 나노입자의 제조 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0180334B1 (ko) 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
KR100360827B1 (ko) * 1999-08-14 2002-11-18 주식회사 삼양사 난용성 약물을 가용화하기 위한 고분자 조성물 및 그의 제조방법
AU2001258872C1 (en) * 2000-05-12 2005-05-26 Samyang Biopharmaceuticals Corporation Method for the preparation of polymeric micelle via phase separation of block copolymer
US7217770B2 (en) * 2000-05-17 2007-05-15 Samyang Corporation Stable polymeric micelle-type drug composition and method for the preparation thereof
CA2463172C (en) * 2001-10-18 2009-08-18 Samyang Corporation Polymeric micelle composition with improved stability
EP2229417B1 (en) * 2007-12-31 2014-07-30 Samyang Biopharmaceuticals Corporation Process for the preparation of highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid
KR101024742B1 (ko) * 2007-12-31 2011-03-24 주식회사 삼양사 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법
US9801818B2 (en) * 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same
CN101444510B (zh) 2008-12-31 2011-03-09 南京卡文迪许生物工程技术有限公司 含有伏立康唑的药物制剂及其制备方法
CN104758256B (zh) * 2014-02-14 2016-05-04 苏州海特比奥生物技术有限公司 一种多西他赛纳米聚合物胶束冻干制剂及其制备方法

Also Published As

Publication number Publication date
BR112018001736A2 (pt) 2018-09-11
EP3328434A4 (en) 2019-03-13
RU2018107052A3 (es) 2019-08-28
WO2017018816A1 (en) 2017-02-02
JP2018521094A (ja) 2018-08-02
KR101748191B1 (ko) 2017-06-19
CN111574702A (zh) 2020-08-25
EP3328434A1 (en) 2018-06-06
ZA201801189B (en) 2019-01-30
HK1249439A1 (zh) 2018-11-02
RU2018107052A (ru) 2019-08-28
CA2993920A1 (en) 2017-02-02
CN106559983A (zh) 2017-04-05
KR20170015198A (ko) 2017-02-08
AU2016299544A1 (en) 2018-03-08
JP6605706B2 (ja) 2019-11-13
IL257185A (en) 2018-03-29

Similar Documents

Publication Publication Date Title
IL285359B1 (en) Anaerobic blood storage containers
EP3274841A4 (en) Compaction for memory hierarchies
EP3130355A4 (en) Pharmaceutical composition containing pregabalin with improved stability and method for preparing same
PT3297641T (pt) Métodos de armazenamento de sangue total e respetivas composições
ZA201706229B (en) Method for preparing inhibited starch with improved warehouse storage stability
EP3207149A4 (en) Pharmaceutical composition with improved stability
SG11201800273PA (en) Container for cell administration, storage or culturing
EP3296285A4 (en) Ester-based compound, composition containing same, method for preparing same, and resin composition containing same
PL3231417T3 (pl) Odporna na składowanie kompozycja oftalmiczna
EP3257791A4 (en) Planar storage facility
BR112017002139A2 (pt) ?método para preparar um composto?
PH12017502148A1 (en) Pharmaceutical compositions and use thereof
HUE047537T2 (hu) Új heterociklusos vegyület, eljárás annak elõállítására, és az azt tartalmazó gyógyászati készítmény
MX2018001221A (es) Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.
MX2018001219A (es) Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.
MX2018001223A (es) Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.
MX2018001222A (es) Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.
EP3304051A4 (en) Compounds for labeling amine-containing compounds, and their use
GB2547330B (en) Storage arrangement for well operations
EP3296286A4 (en) Ester-based compound, composition containing same, method for preparing same, and resin composition containing same
EP3206683A4 (en) Novel methods, compounds, and compositions for anesthesia
EP3138830A4 (en) Composition containing 3-chloro-4-methoxybenzylamine hydrochloride, and method for producing same
HK40007613A (zh) 储存盒
AU2015902697A0 (en) Composition and system for gas storage
AU2016900077A0 (en) Storage arrangement